Difference between revisions of "Purple glove syndrome"

From WikEM
Jump to: navigation, search
 
(One intermediate revision by one other user not shown)
Line 2: Line 2:
 
*Uncommon skin complication of [[phenytoin]]
 
*Uncommon skin complication of [[phenytoin]]
 
*Typically associated with IV infiltration of phenytoin, but poorly understood pathophysiology
 
*Typically associated with IV infiltration of phenytoin, but poorly understood pathophysiology
**Proposed mechanisms include: <ref>Bhattacharjee P.. Early histopathologic changes in purple glove syndrome. J Cutan Pathol. 2004;31(7):513-5.</ref>
+
*Proposed mechanisms include:<ref>Bhattacharjee P.. Early histopathologic changes in purple glove syndrome. J Cutan Pathol. 2004;31(7):513-5.</ref>
***chemical irritation from added propylene glycol and sodium hydroxide
+
**Chemical irritation from added propylene glycol and sodium hydroxide
***vasoconstriction
+
**Vasoconstriction
***vasculitis
+
**Vasculitis
***microthrombus formation
+
**Microthrombus formation
*** phenytoin leakage into soft tissue with subsequent edema  
+
**Phenytoin leakage into soft tissue with subsequent edema  
 
*Generally develops within first 24 hours after infusion, resolves within days to weeks <ref> Santoshi JA. Purple glove syndrome: a case report. Hand surgeons and physicians be aware. J Plast Reconstr Aesthet Surg. 2010;63(3):e340-2.</ref>
 
*Generally develops within first 24 hours after infusion, resolves within days to weeks <ref> Santoshi JA. Purple glove syndrome: a case report. Hand surgeons and physicians be aware. J Plast Reconstr Aesthet Surg. 2010;63(3):e340-2.</ref>
  
 
[[File:Purple_glove_syndrome.png|thumb|]]
 
[[File:Purple_glove_syndrome.png|thumb|]]
 
  
 
==Clinical Features==
 
==Clinical Features==
Line 19: Line 18:
  
 
==Differential Diagnosis==
 
==Differential Diagnosis==
 +
  
 
==Evaluation==
 
==Evaluation==
 
*Clinical diagnosis based on history and exam
 
*Clinical diagnosis based on history and exam
 +
 
==Management==
 
==Management==
 
*Optimal management remains unclear
 
*Optimal management remains unclear
Line 30: Line 31:
 
*Consider vascular or hand consult if digital or skin necrosis suspected
 
*Consider vascular or hand consult if digital or skin necrosis suspected
 
**Anticoagulation is occasionally started (no clear evidence that it is effective) <ref>Scumpia AJ. Purple glove syndrome after intravenous phenytoin administration presenting in the emergency department. J Emerg Med. 2013;44(2):e281-3.</ref>
 
**Anticoagulation is occasionally started (no clear evidence that it is effective) <ref>Scumpia AJ. Purple glove syndrome after intravenous phenytoin administration presenting in the emergency department. J Emerg Med. 2013;44(2):e281-3.</ref>
 +
 
==Disposition==
 
==Disposition==
 
*Given possibility of severe outcomes, recommend 24 hours of observation in asymptomatic patients
 
*Given possibility of severe outcomes, recommend 24 hours of observation in asymptomatic patients
Line 39: Line 41:
  
 
==External Links==
 
==External Links==
 +
  
 
==References==
 
==References==
 
<references/>
 
<references/>
  
[[Category:Toxicology]] [[Category:Dermatology]]
+
[[Category:Toxicology]]
 +
[[Category:Dermatology]]

Latest revision as of 01:16, 10 May 2017

Background

  • Uncommon skin complication of phenytoin
  • Typically associated with IV infiltration of phenytoin, but poorly understood pathophysiology
  • Proposed mechanisms include:[1]
    • Chemical irritation from added propylene glycol and sodium hydroxide
    • Vasoconstriction
    • Vasculitis
    • Microthrombus formation
    • Phenytoin leakage into soft tissue with subsequent edema
  • Generally develops within first 24 hours after infusion, resolves within days to weeks [2]
Purple glove syndrome.png

Clinical Features

  • Peripheral edema, blistering, pain, and discoloration of the extremity receiving intravenous phenytoin
  • Pulses and sensation may be diminished
  • Skin necrosis may develop

Differential Diagnosis

Evaluation

  • Clinical diagnosis based on history and exam

Management

  • Optimal management remains unclear
  • Some case reports found improvement with
    • topical nitroglycerin
    • brachial plexus nerve block
    • elevation, heat application, soft tissue massage
  • Consider vascular or hand consult if digital or skin necrosis suspected
    • Anticoagulation is occasionally started (no clear evidence that it is effective) [3]

Disposition

  • Given possibility of severe outcomes, recommend 24 hours of observation in asymptomatic patients

See Also

External Links

References

  1. Bhattacharjee P.. Early histopathologic changes in purple glove syndrome. J Cutan Pathol. 2004;31(7):513-5.
  2. Santoshi JA. Purple glove syndrome: a case report. Hand surgeons and physicians be aware. J Plast Reconstr Aesthet Surg. 2010;63(3):e340-2.
  3. Scumpia AJ. Purple glove syndrome after intravenous phenytoin administration presenting in the emergency department. J Emerg Med. 2013;44(2):e281-3.